Effect of Music Therapy on Patients Undergoing Intravitreal Injections
Recruitment status was: Recruiting
Multiple studies in various specialties, including ophthalmology, are reported in the literature that show that playing music during a procedure (dubbed music therapy) increases patient satisfaction and may reduce patient anxiety and stress levels.
There is no study in the literature that assesses the effects of listening to music in patients undergoing intravitreal injections. This study aims to assess whether listening to music improves patient satisfaction or reduces their anxiety levels in subjects undergoing intravitreal injections.
|Intravitreal Injections Patient Satisfaction Patient Anxiety||Other: No Music Other: Music Therapy|
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Effect of Music Therapy on Patients Undergoing Intravitreal Injections|
- This study aims to assess what affects music therapy has on patients receiving intravitreal injections. The subject will take a Satisfaction Survey after the procedure and an Anxiety Survey before and after the injection. [ Time Frame: Before and after the subject's intravitreal injection. ]
|Study Start Date:||February 2007|
|Estimated Study Completion Date:||February 2009|
|Estimated Primary Completion Date:||February 2009 (Final data collection date for primary outcome measure)|
Those patients receiving intravitreal injections who will be listening to classical music during injection.
Other: Music Therapy
Classical music being played during intravitreal injection.
Those patients receiving intravitreal injections who will not be listening to any music during injection.
Other: No Music
No music will be played in patients in arm 2 of the study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00702039
|Contact: Rajeev Seth, MD||203-785-2020|
|United States, Connecticut|
|Yale Eye Center||Recruiting|
|New Haven, Connecticut, United States, 06510|
|Contact: Rajeev Seth, MD 203-785-2020|
|Principal Investigator:||Ron Adelman, MD||Yale University Department of Ophthalmology|